In our January issue of Pharmaceutical Executive
FEATURES
Cover Story
Biopharma Change Agent: Belén Garijo, CEO Healthcare, Merck KGaA, Darmstadt, Germany
William Looney
Pharm Exec sits down with Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany's healthcare business, who shares her approach in transforming a traditional pharma unit focused on small molecules for chronic disease to a high-tech specialty producer of immunotherapy drugs for rare cancers. |
Forecast
Path of Uncertainty: Pharm Exec's 2017 Industry Outlook
Julian Upton, Casey McDonald
Despite industry's success in translating discovery research into products with proven clinical value, it continues to struggle in positioning medical research to the public as a distinctive force for good. |
Information Technology
The 'Healthcare Internet of Things'
William King
Connected ecosystems will change the future of healthcare. William King outlines three key value drivers. |
Commercialization
War Games: Win Your Brand with Action!
Stan Bernard
Stan Bernard outlines the seven ways for pharmas to ensure successful execution of action steps following brand 'war games'. |
 |
ALSO IN THIS ISSUE
Pharma and Biotech Markets: Challenges and Opportunities
Peter Young
With soaring valuations of companies in the public and M&A markets now a distant memory, the challenge for industry will be choosing the right mix of M&A, licensing, and partnering …Read more
Research Responses to Data Privacy Concerns
Peter Houston
How can pharma balance the need to access to patient data and still respect patient privacy? One approach is to access patients through third-party online communities.…Read more
Connecting the Dots for an Enraged Media
Casey McDonald
Rethinking views on limited-efficiency approvals may be in order…Read more
|
|
| |
| WEBCASTS |
| Commercializing Drugs with Companion Diagnostics |
| How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors |
Supporting internal and external decision-making through effective MSL activities
|
Achieving Success in the Biosimilar Market
|
Why Patient Support Programs Need a Personal Approach
|
